Research Results of the Opioidrisk Core Training Activity

This page provides a short summary of our summative evaluation results of the Opioidrisk Core Training Activity. To see more results, please see our Summative Study Results PDF.

Clinical Tools, Inc. created the Opioidrisk Core Training Activity, to train health care providers in how to prescribe opioids safely and only when indicated, minimizing risk of addiction, misuse, diversion, and overdose. The curriculum plan was developed based on a needs analysis of the practice gaps found in the literature and described by target audience members as well as by experts in the field. Between January-March 2011, the summative evaluation of the entire activity was completed by 40 physician members of the target audience.


Pre-/Post- Knowledge & Clinical Skills

Mean scores for a knowledge multiple choice exam as well as a separate multiple choice clinical skills quiz showed significant pre- to post-training improvement.

Knowledge & Clinical Skills

Average (Pre) Average (Post) SD (Pre) SD (Post) P value
Knowledge 55% 75% 20.4 14.6 p ≤ 0.0001
Clinical Skills 57% 69% 22.1 19.2 p ≤ 0.005

Pre-/Post- Attitude

Mean agreement with ideal attitude statements increased from 4.17 to 4.3 on a 5 point Likert scale, p ≤ 0.05.

Attitude Pre/Post
Please rate the following statements on a 5 point Likert scale (1=Strongly Disagree, 5=Strongly Agree) Agree or Strongly Agree Average
Pre Post Pre Post
It is possible to prescribe opioids for chronic pain without addiction developing. 68% 93% 3.9 4.3
Urine drug testing is an important tool for use with all patients on chronic opioid therapy. 73% 83% 3.9 4.2
Treatment agreements are important tools in reducing risk of substance misuse in chronic opioid treatment. 75% 88% 4.2 4.3


Intention to perform recommended practice behaviors increased for each behavior and was significant for 6/8 behaviors, p ≤ .0058 to 0.03. The three behaviors exhibiting the greatest change were related to conducting urine drug testing, using the least addictive drug possible, and using a written treatment agreement with patients on chronic opioid therapy.

Self Efficacy

The participants exhibited a high level of self efficacy after taking each module. The majority of participants (87% to 97%) agreed or strongly agreed with each self-efficacy statement related to module objectives.

Educational value and Satisfaction

Educational value. The majority of participants agreed that the activity improved:

  • Knowledge (90%)
  • Competence (85%) and
  • Performance (70%)

Participant agreement was fairly strong (mean 4.3/5) that the activity promoted evidence-based practice and working in interdisciplinary teams and that the activity was patient-centered. Participants generally agreed that the activity would impact their practice (Mean agreement=4.2/5).

Satisfaction. Means ratings for six satisfaction statements ranged from 4.1 to 4.3 on a 5 point Likert scale.

Amount of Agreement Satisfaction Statement Rate of Agreement/Strong Agreement
Statements having the highest agreement “This activity was presented objectively and was free of commercial bias.” 100%
Statement having the lowest agreement “The material was organized clearly for learning to occur.” 88%

These results suggest we have developed an activity that will improve clinical practice to minimize the risk of prescription opioid misuse, and thus, patient outcomes.